On June 22nd in Hong Kong, Luye Pharma Group hosted a conference to unveil their Global Collaboration Strategy. Liu Dianbo, Chairman of Luye Pharma Group, said at the event, “Starting in 2019, Luye P...
SINGAPORE, 10 April 2018 – Luye Medical Group (the “Company”), a leading pan-Asian healthcare services provider, announced that it has recently completed a majority equity investment in Novena...
Luye Pharma announced that its new investigational drug, Rotigotine Extended Release Microspheres for Injection (LY03003) for the treatment of Parkinson’s disease has been submitted to the Pharm...
Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications, today announced that it has entered the final stage of New Drug A...
TOP